BICARA THERAPEUTICS INC (BCAX) Stock Analyst Ratings
USA - NASDAQ:BCAX - US0554771032 - Common Stock
14.97 USD
-0.08 (-0.53%)
ChartMill assigns a Buy % Consensus number of 83% to BCAX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 32.79. This target is 119.01% above the current price.
BCAX was analyzed by 15 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BCAX.
In the previous month the buy percentage consensus was at a similar level.
BCAX was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-11 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-19 | Piper Sandler | Initiate | Overweight |
| 2025-05-23 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |
| 2025-05-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-17 | Wells Fargo | Initiate | Underweight |
| 2025-04-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-13 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-02-12 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-02-06 | Wedbush | Initiate | Outperform |
| 2025-01-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-06 | HC Wainwright & Co. | Initiate | Buy |
| 2024-10-08 | TD Cowen | Initiate | Buy |
| 2024-10-08 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-10-08 | Stifel | Initiate | Buy |
| 2024-10-08 | Morgan Stanley | Initiate | Overweight |
BICARA THERAPEUTICS INC / BCAX FAQ
What is the average price target for BICARA THERAPEUTICS INC (BCAX) stock?
15 analysts have analysed BCAX and the average price target is 32.79 USD. This implies a price increase of 119.01% is expected in the next year compared to the current price of 14.97.
Can you provide the consensus rating for BICARA THERAPEUTICS INC stock?
The consensus rating for BICARA THERAPEUTICS INC (BCAX) is 82.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.